Navegar

Colección

Datos Estadísticas

Lista de

epithelial mesenchymal transition
9
"High RAC3 expression levels are required for induction and maintaining of cancer cell stemness" (2018) Panelo, L.C.;Machado, M.S.;Rubio, M.F. (...)Costas, M.A. Oncotarget. 9(5):5848-5860
"R-Spondin3 is associated with basal-progenitor behavior in normal and tumor mammary cells" (2018) Tocci, J.M.;Felcher, C.M.;García Sola, M.E. (...)Kordon, E.C. Cancer Research. 78(16):4497-4511
"Angiotensin-(1-7) counteracts the transforming effects triggered by angiotensin II in breast cancer cells" (2017) Cambados, N.;Walther, T.;Nahmod, K. (...)Schere-Levy, C. Oncotarget. 8(51):88475-88487
"CtBP1 associates metabolic syndrome and breast carcinogenesis targeting multiple miRNAs" (2016) De Luca, P.;Dalton, G.N.;Scalise, G.D. (...)De Siervi, A. Oncotarget. 7(14):18798-18811
"Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways" (2016) Rabinovich, G.A.; Conejo-García, J.R. Journal of Molecular Biology. 428(16):3266-3281
"Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells" (2016) Castillo, L.F.;Tascón, R.;Huvelle, M.A.L. (...)Peters, M.G. Oncotarget. 7(37):60133-60154
"Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells" (2016) Castillo, L.F.;Tascón, R.;Huvelle, M.A.L. (...)Peters, M.G. Oncotarget. 7(37):60133-60154
"BRCA1 and p53 regulate critical prostate cancer pathways" (2013) De Luca, P.;Moiola, C.P.;Zalazar, F. (...)De Siervi, A. Prostate Cancer and Prostatic Diseases. 16(3):233-238
"Key questions in metastasis: New insights in molecular pathways and therapeutic implications" (2011) Gueron, G.; de Siervi, A.; Vazquez, E. Current Pharmaceutical Biotechnology. 12(11):1867-1880